Regulation of apoptosis by PI 3-kinase/Akt signaling
Regulation of apoptosis by PI 3-kinase/Akt signaling
批准号:
7942252
负责人:
GEOFFREY M COOPER
金额:
$22.85万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-05-31
关键词:
1-Phosphatidylinositol 3-Kinase3&apos Untranslated RegionsAddressAffectApoptosisApoptosis RegulatorBinding ProteinsBinding SitesBiological AssayCREB1 geneCell CycleCell ProliferationCell SurvivalCellsComputer AnalysisDistantElementsEnhancersFamilyGene ExpressionGene Expression ProfilingGene Expression RegulationGene TargetingGenesGenetic TranscriptionGlycogen Synthase Kinase 3GoalsGrantGrowth FactorHuman DevelopmentImmediate-Early GenesMalignant NeoplasmsMammalian CellMediatingMessenger RNAMolecular ProfilingMutationNucleic Acid Regulatory SequencesPathway interactionsPhysiologicalPlayProliferatingPromoter RegionsRNA InterferenceRegulationRegulator GenesResearchRoleSerumSignal PathwaySignal TransductionTestingTranscriptTranscription factor genesTranscriptional RegulationTransfectionbasecancer therapycell growthchromatin immunoprecipitationdrug developmentexperimental analysismRNA StabilitymRNA Transcript Degradationmembernovelprogramspromoterpublic health relevanceresearch studyresponsetranscription factortranscription factor USF
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall goal of the proposed research is to elucidate the mechanisms by which the PI 3-kinase/Akt/GSK-3 signaling pathway regulates cell growth and survival. Both Akt and GSK-3 phosphorylate multiple transcription factors, but the overall program of gene expression controlled by PI 3-kinase/Akt/GSK-3 signaling remains to be fully understood. During the past grant period, global expression profiling combined with computational/experimental analysis of transcription factor binding sites has been used to characterize gene regulation by PI 3-kinase/Akt/GSK-3 signaling, both following growth factor stimulation of quiescent cells and during the continuous proliferation of cells maintained in serum. These studies identified CREB as a key transcription factor targeted by GSK-3 in quiescent cells, and have further implicated members of the AP-1, NFkB and NFAT transcription factor families as GSK-3 targets. A distinct set of genes, enriched in regulators of programmed cell death, is controlled by continuous PI 3-kinase signaling in proliferating cells. Computational analysis of upstream regulatory regions combined with chromatin immunoprecipitation assays indicate that FOXO, NFkB and Myc/Mad/Max transcription factors play major roles in regulation of these genes. In addition, computational analysis of the 3' untranslated regions of their mRNAs suggests that mRNA turnover is also involved in gene regulation by PI 3-kinase signaling. These studies will be continued with the goal of elucidating the program of gene regulation controlled by PI 3-kinase/Akt/GSK-3 signaling, including regulation of mRNA stability. The proposed experiments will proceed according to the following specific aims. 1. Characterization of the transcriptional program regulated by GSK-3 in quiescent cells. The roles of AP-1, NFkB and NFAT transcription factors will be investigated by chromatin immunoprecipitation and RNA interference. Computational analysis will be expanded to identify transcription factor binding sites in predicted enhancers as well as promoter regions, and the role of GSK-3 in regulation of delayed primary response as well as immediate-early genes will be studied. 2. Transcriptional regulation by PI 3-kinase/Akt/GSK-3 signaling in proliferating cells. RNA interference and transient transfection assays will be used to determine the roles of FOXO, NFkB and Myc/Mad/Max transcription factors in PI 3-kinase-dependent gene expression in proliferating cells. The role of GSK-3 in gene regulation during cell proliferation will also be investigated. 3. Regulation of mRNA stability. The role of mRNA degradation in gene regulation by PI 3-kinase will be investigated by determining the effect of PI 3-kinase/Akt/GSK-3 signaling on the stability of mRNAs that are down-regulated following inhibition of PI 3-kinase. PUBLIC HEALTH RELEVANCE: Mutations affecting the PI 3-kinase/Akt/GSK-3 signaling pathway are among the most common abnormalities leading to the development of human cancer, and components of this pathway are active targets for drug development. The present proposal seeks to further understand the mechanism by which this pathway regulates cell survival. Discoveries of novel targets of PI 3-kinase signaling may provide new targets for cancer treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PROTO-ONCOGENES IN GAMETOGENESIS AND EARLY DEVELOPMENT
-
批准号:2883127
-
项目类别:
-
资助金额:$24.88万
-
财政年份:1998
-
负责人:GEOFFREY M COOPER
-
依托单位:
PROTO-ONCOGENES IN GAMETOGENESIS AND EARLY DEVELOPMENT
-
批准号:2668576
-
项目类别:
-
资助金额:$24.14万
-
财政年份:1998
-
负责人:GEOFFREY M COOPER
-
依托单位:
PROTO-ONCOGENES IN GAMETOGENESIS AND EARLY DEVELOPMENT
-
批准号:2378511
-
项目类别:
-
资助金额:$23.53万
-
财政年份:1996
-
负责人:GEOFFREY M COOPER
-
依托单位:
PROTO-ONCOGENES IN GAMETOGENESIS AND EARLY DEVELOPMENT
-
批准号:2199996
-
项目类别:
-
资助金额:$23.39万
-
财政年份:1996
-
负责人:GEOFFREY M COOPER
-
依托单位:
PROTO-ONCOGENES IN GAMETOGENESIS AND EARLY DEVELOPMENT
-
批准号:3328088
-
项目类别:
-
资助金额:$31.19万
-
财政年份:1989
-
负责人:GEOFFREY M COOPER
-
依托单位:
PROTO-ONCOGENES IN GAMETOGENESIS AND EARLY DEVELOPMENT
-
批准号:3328086
-
项目类别:
-
资助金额:$29.04万
-
财政年份:1989
-
负责人:GEOFFREY M COOPER
-
依托单位:
PROTO-ONCOGENES IN GAMETOGENESIS AND EARLY DEVELOPMENT
-
批准号:3328087
-
项目类别:
-
资助金额:$28.74万
-
财政年份:1989
-
负责人:GEOFFREY M COOPER
-
依托单位:
PROTO-ONCOGENES IN GAMETOGENESIS AND EARLY DEVELOPMENT
-
批准号:3328084
-
项目类别:
-
资助金额:$21.23万
-
财政年份:1989
-
负责人:GEOFFREY M COOPER
-
依托单位:
PROTO-ONCOGENES IN GAMETOGENESIS AND EARLY DEVELOPMENT
-
批准号:2199993
-
项目类别:
-
资助金额:$30.57万
-
财政年份:1989
-
负责人:GEOFFREY M COOPER
-
依托单位:
TRANSFECTION BY ENDOGENOUS HUMAN TRANSFORMING GENES
-
批准号:3168442
-
项目类别:
-
资助金额:$16.63万
-
财政年份:1981
-
负责人:GEOFFREY M COOPER
-
依托单位:
TRANSFECTION BY ENDOGENOUS HUMAN TRANSFORMING GENES
-
批准号:3168444
-
项目类别:
-
资助金额:$16.72万
-
财政年份:1981
-
负责人:GEOFFREY M COOPER
-
依托单位:
TRANSFECTION BY ENDOGENOUS HUMAN TRANSFORMING GENES
-
批准号:3168445
-
项目类别:
-
资助金额:$17.52万
-
财政年份:1981
-
负责人:GEOFFREY M COOPER
-
依托单位:
TRANSFECTION BY ENDOGENOUS HUMAN TRANSFORMING GENES
-
批准号:3168443
-
项目类别:
-
资助金额:$16.04万
-
财政年份:1981
-
负责人:GEOFFREY M COOPER
-
依托单位:
TRANSFECTION BY ENDOGENOUS HUMAN TRANSFORMING GENES
-
批准号:3168441
-
项目类别:
-
资助金额:$1.83万
-
财政年份:1981
-
负责人:GEOFFREY M COOPER
-
依托单位:
INFECTIOUS DNA FOR ENDOGENOUS RNA TUMOR VIRUS GENES
-
批准号:2086717
-
项目类别:
-
资助金额:$29.36万
-
财政年份:1976
-
负责人:GEOFFREY M COOPER
-
依托单位:
Regulation of apoptosis by PI 3-kinase/Akt signaling
-
批准号:7807149
-
项目类别:
-
资助金额:$49.16万
-
财政年份:1976
-
负责人:GEOFFREY M COOPER
-
依托单位:
Regulation of apoptosis by PI 3-kinase/Akt signaling
-
批准号:7643339
-
项目类别:
-
资助金额:$48.46万
-
财政年份:1976
-
负责人:GEOFFREY M COOPER
-
依托单位:
INFECTIOUS DNA FOR ENDOGENOUS RNA TUMOR VIRUS GENES
-
批准号:2086718
-
项目类别:
-
资助金额:$32.87万
-
财政年份:1976
-
负责人:GEOFFREY M COOPER
-
依托单位:
INFECTIOUS DNA FOR ENDOGENOUS RNA TUMOR VIRUS GENES
-
批准号:3165030
-
项目类别:
-
资助金额:$20.13万
-
财政年份:1976
-
负责人:GEOFFREY M COOPER
-
依托单位:
INFECTIOUS DNA FOR ENDOGENOUS RNA TUMOR VIRUS GENES
-
批准号:2856191
-
项目类别:
-
资助金额:$39.26万
-
财政年份:1976
-
负责人:GEOFFREY M COOPER
-
依托单位:
国内基金
登录
查看更多内容
3'-甲氧基葛根素生物合成途径中关键甲基转移酶基因的克隆与功能分析
-
批准号:31300258
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:黎佳
-
依托单位:
晚期妊娠维持和抑制早产中cAMP信号活化PR的作用机制研究
-
批准号:81300507
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2013
-
负责人:陈黎
-
依托单位:
3'-UTR单核苷酸多态性影响CYP8B1基因表达致胆囊胆固醇结石形成的机制研究
-
批准号:81370561
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:秦俭
-
依托单位:
异源杂交多倍化鲫鲤特有性状的转录组及后转录组水平变化规律研究
-
批准号:31360514
-
项目类别:地区科学基金项目
-
资助金额:54.0万元
-
批准年份:2013
-
负责人:罗静
-
依托单位:
HIF基因3'UTR区SNP参与胰腺癌HIF-1α表达调控的分子机制及功能研究
-
批准号:81302082
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王秀超
-
依托单位:
鼻咽癌转移相关通路分子的microRNA调控机制及3'UTR区可变剪切的作用研究
-
批准号:81372886
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:买世娟
-
依托单位:
小鼠精原干细胞中APA位点研究及3'UTR使用频率数据库构建
-
批准号:31301085
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2013
-
负责人:熊远妍
-
依托单位: